Ionizing radiation microbeam facilities for radiobiological studies in Europe.
A growing body of experimental evidence gathered in the last 10-15 years with regard to targeted and non-targeted effects of low doses of ionizing radiation (hyper-radiosensitivity, induced radio-resistance, adaptive response, genomic instability, bystander effects) has pushed the radiobiology research towards a better understanding of the mechanisms underlying these phenomena, the extent to which they are active in-vivo, and how they are inter-related. In such a way factors could be obtained and included in the estimation of potential cancer risk to the human population of exposure to low levels of ionizing radiation. Different experimental approaches have been developed and employed to study such effects in-vitro (medium transfer experiments; broad-field irradiation at low doses also with insert or shielding systems...). In this regard, important contributions came from ionizing radiation microbeam facilities that turn to be powerful tools to perform selective irradiations of individual cells inside a population with an exact, defined and reproducible dose (i.e. number of particles, in case of charged particle microbeams). Over the last 20 years the use of microbeams for radiobiological applications increased substantially and a continuously growing number of such facilities, providing X-rays, electrons, light and heavy ions, has been developing all over the world. Nowadays, just in Europe there are 12 microbeam facilities fully-operational or under-development, out of more than 30 worldwide. An overview of the European microbeam facilities for radiobiological studies is presented and discussed in this paper.